Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Systemic Lupus Erythematosus Clinical Trials
Systemic Lupus Erythematosus clinical trials are recruiting across 157 cities. Here are the cities with the most active studies:
Systemic Lupus Erythematosus Trial Phases
69 research organizations are sponsoring systemic lupus erythematosus trials.
About Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, blood cells, brain, heart, and lungs. It is characterized by periods of flares and remission. Treatment includes antimalarials, immunosuppressants, corticosteroids, and biologics like belimumab.
Clinical trials are advancing new treatments for systemic lupus erythematosus. Currently, 100 studies are recruiting a combined 190,718 participants across the United States. Research is being conducted by 69 organizations including Scripps Translational Science Institute, Mayo Clinic, Lupus Foundation of America and 66 others.
2026 Systemic Lupus Erythematosus Research Landscape
As of July 2026, the systemic lupus erythematosus clinical trial landscape includes 100 actively recruiting studies across 157 cities in the United States. These studies are collectively seeking 190,718 participants, with an average enrollment target of 1,907 per study.
The research spans multiple phases of development: 40 studies are in NA, 17 studies are in PHASE2, 12 studies are in PHASE3, 7 studies are in PHASE1, 6 studies are in PHASE4. The presence of Phase 3 trials indicates that some systemic lupus erythematosus treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 69 different organizations, including Scripps Translational Science Institute, Mayo Clinic, Lupus Foundation of America, Vanda Pharmaceuticals, Children's Hospital of Philadelphia, and 64 others. The large number of sponsors reflects significant research interest and investment in systemic lupus erythematosus treatment advancement.
Geographically, systemic lupus erythematosus trials are most concentrated in Miami, Florida (12 trials); Chicago, Illinois (10 trials); Los Angeles, California (9 trials); Philadelphia, Pennsylvania (8 trials); Atlanta, Georgia (8 trials) and 7 other cities.
Featured Systemic Lupus Erythematosus Studies
Highlighted recruiting studies for systemic lupus erythematosus, selected by enrollment size and research scope.
Research Framework Exploring Sleep Health
This is a digital health study in which participants are recruited to collect sleep and activity data from digital activity trackers. We are also collecting survey/questionnaire data on baseline health and sleep characteristics as well as bi-weekly assessments of sleep quality and mood. Overall, we aim to examine how sleep relates to physical and mental health in a large population of activity tra...
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders...
Research Accelerated by You Lupus Registry
Summary The Lupus Foundation of America (LFA) Research Accelerated by You (RAY) Registry is a fully remote, longitudinal registry designed to collect data from adults and children living with lupus. The primary goal is to better understand the diagnosis, treatment, care, and quality of life for those affected by the disease. Remote Participation This is a decentralized, online-only registry. Part...
Frequently Asked Questions About Systemic Lupus Erythematosus Clinical Trials
Are there systemic lupus erythematosus clinical trials near me?
Yes, there are 100 systemic lupus erythematosus clinical trials currently recruiting across 157+ cities in the United States, including Miami, Florida; Chicago, Illinois; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a systemic lupus erythematosus clinical trial?
To join a systemic lupus erythematosus clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are systemic lupus erythematosus clinical trials free?
Yes, participation in systemic lupus erythematosus clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of systemic lupus erythematosus treatments are being studied?
Current systemic lupus erythematosus clinical trials are testing a range of approaches across NA (40 studies), PHASE2 (17 studies), PHASE3 (12 studies), PHASE1 (7 studies), PHASE4 (6 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 69 research organizations.
Is it safe to participate in systemic lupus erythematosus clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov